PHILADELPHIA – David B. Roth, MD, PhD has been appointed chair of Penn Medicine’s Department of Pathology and Laboratory Medicine, effective July 1, 2011.
Currently the Irene Diamond Professor of Immunology and Chair of the Department of Pathology at NYU Langone Medical Center, Roth brings extensive experience as an educator, researcher and medical leader to the Penn Medicine position.
Roth’s teaching at Baylor and NYU Langone garnered many teaching awards, including the Distinguished Teacher in the Basic Sciences Award from Langone’s 2008 graduating class. Among Roth’s educational successes includes creating a new pathobiology program at Langone.
A frequent recipient of support from the National Institutes of Health, Roth’s research and clinical interests include DNA repair and the mechanisms of programmed gene rearrangements during lymphocyte differentiation, and the study of Omenn syndrome.
In addition to serving as one of the editors of Immunology, 7th edition, and participating on the editorial boards of Nucleic Acids Research and Mobile DNA, Roth is a reviewer for numerous scientific journals, including Cell, Science, Nature, and Nature Genetics. Roth has been a site reviewer for the National Cancer Institute and organized the First International Symposium on DNA Enzymes. Roth was elected to the American Association of University Pathologists (The Pluto Society) and is a member of the American Association for the Advancement of Science and The New York Academy of Sciences.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.